Safety Concerns Over Larger Bottle For ISTA's Bromday Could Impact Other Eye Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Center for Drug Evaluation and Research refused to approve ISTA's sNDA for a larger fill size of the topical non-steroidal anti-inflammatory because it does not believe a single bottle should be used to dose drug in both eyes.